Growth hormone and insulin-like growth factor I augment Escherichia coli-killing activity of murine peritoneal exudative cells

Shock. 1996 Nov;6(5):345-50. doi: 10.1097/00024382-199611000-00008.

Abstract

Effects of growth hormone (GH) and insulin-like growth factor (IGF)-I on Escherichia coli-killing activity of murine peritoneal exudative cells (PECs) were investigated. Plasma from the mice, injected subcutaneously with saline, GH (4.8 mg/kg/day), or IGF-I(24 mg/kg/day) for 6 days, was mixed with E. coli and pooled murine PECs. Plasma from GH- and IGF-I-treated mice modestly but significantly augmented the E. coli-killing activity of PECs, as compared with that from saline controls. Plasma from IGF-I-treated mice also enhanced PEC interleukin 1 production. In the next experiment, PECs preincubated with medium, GH (10-1000 ng/mL), or IGF-I (50-5000 ng/mL) for 3 h were investigated for E. coli-killing activity. Preincubation of PECs with all concentrations of GH and IGF-I significantly enhanced the E. coli-killing activity of PECs, as compared with the medium control. These results indicate that GH and IGF-I enhance phagocytosis and the E. coli-killing activity of PECs, via a modestly increased plasma capacity to support these activities, as well as by a strong direct action.

MeSH terms

  • Animals
  • Blood Bactericidal Activity / drug effects
  • Caseins / pharmacology
  • Cytokines / metabolism
  • Escherichia coli / drug effects*
  • Exudates and Transudates / drug effects
  • Exudates and Transudates / physiology*
  • Female
  • Growth Hormone / blood
  • Growth Hormone / pharmacology*
  • Insulin-Like Growth Factor I / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • Peritoneal Cavity / cytology*
  • Peritoneal Cavity / microbiology
  • Protein Hydrolysates / pharmacology

Substances

  • Caseins
  • Cytokines
  • Protein Hydrolysates
  • trypticase-soy broth
  • Insulin-Like Growth Factor I
  • Growth Hormone